Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors?

Atrial fibrillation in breast cancer therapy: does tamoxifen confer a lower risk than aromatase inhibitors?

Abstract Introduction Aromatase inhibitors (AIs) have been linked to increased atrial fibrillation(AF) risk due to estrogen depletion however tamoxifen's effect on AF remains conflicting. This study investigates the risk of AF associated with AI use compared to tamoxifen in breast cancer patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Patrick A. Kwaah, Samuel A. Mensah, Emmanuel A. Agyemang, Joseph S. Kekrebesi, Daniil Katkov, Abraham Carboo, Grace Appah, Hamza A. Rashid, Jennifer M. Kwan
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Cardio-Oncology
Online Access:https://doi.org/10.1186/s40959-025-00352-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items